REQUEST A DEMO
Total
USD $0.00
Search more companies

Bul Bio - Ntszpb EOOD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Bul Bio - Ntszpb EOOD Profile Updated: July 16, 2020
Buy our report for this company USD 19.99 Most recent financial data: 2019 Available in: English Download a sample report

Bul Bio NCIPD is a state-owned company registered in 2000. It specialises in the manufacture of vaccines, immunostimulators, bioproducts, blood derivatives and allergens. Bul Bio NCIPD's product range features more than 600 medicines. Exports accounted for 49% of its 2010 sales.

Headquarters
Bul. Yanko Sakazov 26
Sofia; Sofia - city; Postal Code: 1504

Contact Details: Purchase the Bul Bio - Ntszpb EOOD report to view the information.

Website: http://www.bulbio.com

Basic Information
Total Employees:
Purchase the Bul Bio - Ntszpb EOOD report to view the information.
Outstanding Shares:
Purchase the Bul Bio - Ntszpb EOOD report to view the information.
Registered Capital:
Purchase the Bul Bio - Ntszpb EOOD report to view the information.
Financial Auditors:
Purchase the Bul Bio - Ntszpb EOOD report to view the information.
Ratings:
Purchase the Bul Bio - Ntszpb EOOD report to view the information.
Incorporation Date:
November 28, 2000
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Company Performance
Financial values in the chart are available after Bul Bio - Ntszpb EOOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
-5.48%
Total operating revenue
-6.91%
Operating profit (EBIT)
-7.6%
EBITDA
-14.19%
Net Profit (Loss) for the Period
-8.91%
Total assets
8.67%
Total equity
6.51%
Operating Profit Margin (ROS)
-0.44%
Net Profit Margin
-0.66%
Return on Equity (ROE)
-2.36%
Quick Ratio
-1.33%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?